CoChat

Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients

Open access
Xing, Xiaofang, Guo, Jianping, Ding, Guangyu, Li, Bo, Dong, Bin, Feng, Qin, Li, Shen, Zhang, Jian, Ying, Xiaomin, Cheng, Xiaojing, Guo, Ting, Du, Hong, Hu, Ying, Zhou, Tao, Wang, Xiaohong, Li, Lin, Li, Qingda, Xie, Meng, Li, Liting, Gao, Xiangyu, Shan, Fei, Li, Ziyu, Jia, Shuqin, Wen, Xianzi, Wang, Jiping, Ji, Jiafu · 2018 · OncoImmunology
Cited by 145

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Although immune checkpoint blockade have demonstrated promising results, their effects on gastric cancer (GC) are under investigation. Understanding the clinical significance of PD1 and its ligands' expression, together with T cell infiltration might provide clues for biomarkers screening in GC immunotherapy. Immunohistochemistry were performed on a tissue microarray including 1,014 GC specimens using PD1, PDL1 and PDL2 antibodies. T cell markers CD3 and CD8 were also stained and quantified by automated image analysis. Correlation with clinical features and outcome were analyzed after controlling for potential confounders including EBV infection, HER2, C-met and PCNA expression. 37.8% of the cases showed membranous PD-L1 expression in tumor cells and 74.9% in infiltrating immune cells. PDL1 expression rate was rather higher in patients without metastasis, in EBV positive group and those with C-met and PCNA expression. GC patients with high level PDL1 expression exhibited better survival. GC Patients with higher T cell infiltration also showed elevated PDL1, PDL2 and PD1 expression and predict favorable outcome, indicating an adaptive immune resistance mechanism may exist. The group of patients infiltrated with lower density CD3+ T cells also without PDL1 expression in tumor cells predict the worst outcome in the subgroup of different PTNM stage, which may suggest an inactive immune status. These results highlights the need to assess both PDL1 expression in all tumor context and the characterization of the GC immune microenvironment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/2162402x.2017.1356144

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 145

Metadata

Authors
Xing, X., Guo, J., Ding, G., Li, B., Dong, B., Feng, Q., Li, S., Zhang, J., Ying, X., Cheng, X., Guo, T., Du, H., Hu, Y., Zhou, T., Wang, X., Li, L., Li, Q., Xie, M., Li, L., Gao, X., Shan, F., Li, Z., Jia, S., Wen, X., Wang, J., & Ji, J.
Venue
OncoImmunology
Published
2017-12-21
Volume
7
Issue
3
Pages
e1356144
ISSN
  • 2162-4011 (ISSN-L)
  • 2162-402X
OpenAlex
W2772456202
Cited by
145
References
13
FWCI
5.92
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients. https://app.cochat.ai/papers/10.1080/2162402x.2017.1356144
The paper
Xing, X., Guo, J., Ding, G., Li, B., Dong, B., Feng, Q., Li, S., Zhang, J., Ying, X., Cheng, X., Guo, T., Du, H., Hu, Y., Zhou, T., Wang, X., Li, L., Li, Q., Xie, M., Li, L., . . . Ji, J. (2018). Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients. OncoImmunology. https://doi.org/10.1080/2162402x.2017.1356144

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.